A review highlighting that Sodium–glucose cotransporter 2 inhibitors (SGLT-2i) not only lower blood sugar in Type 2 diabetes but also significantly reduce the risk of heart failure, hospitalization, and stroke.
Providing this will allow me to pinpoint the exact, helpful content you need. 111249
If you were looking for a different "111249" (e.g., a specific product code, dataset, or news article), please provide more context. To help you further, could you please tell me: a specific product code